BrdU anticorps

N° du produit ABIN1302495

Cet anticorps anti-BrdU est un anticorps Souris Monoclonal détectant BrdU dans FACS, IHC (p) et IHC (fro). Adapté pour . Ce Primary Antibody a été cité dans 7+ publications.

Aperçu rapide pour BrdU anticorps (ABIN1302495)

Antigène: BrdU (Bromodeoxyuridine (BrdU))

Reactivité: Veuillez nous consulter SVP

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp BrdU est non-conjugé

Application: Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Clone: Bu20a

Détail du produit anti-BrdU anticorps

Fonction: Anti-BrdU Purified

Specificité: The antibody Bu20a reacts specifically with BrdU incorporated into DNA during S-phase of a cell cycle. It is useful for detecting proliferating cells by flow cytometry or immunohistochemistry staining. It cross-reacts with EdU.

Purification: Purified by protein-A affinity chromatography.

Pureté: > 95 % (by SDS-PAGE)

Immunogène: Bromodeoxyuridine conjugated to BSA

Isotype: IgG1

Information d'application

Indications d'application: Flow cytometry: Recommended dilution: 1-5 μg/mL. Intracellular staining.

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/mL

Buffer: Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Do not freeze.

Stock: 4 °C

Stockage commentaire: Store at 2-8°C. Do not freeze.

Références pour anticorps anti-BrdU (ABIN1302495)

Yatera, Hsieh, Hogg, Tranfield, Suzuki, Shih, Behzad, Vincent, van Eeden: "Particulate matter air pollution exposure promotes recruitment of monocytes into atherosclerotic plaques." dans: American journal of physiology. Heart and circulatory physiology, Vol. 294, Issue 2, pp. H944-53, (2008) (PubMed).

ODriscoll, Jeggo: "CsA can induce DNA double-strand breaks: implications for BMT regimens particularly for individuals with defective DNA repair." dans: Bone marrow transplantation, Vol. 41, Issue 11, pp. 983-9, (2008) (PubMed).

Pajalunga, Mazzola, Salzano, Biferi, De Luca, Crescenzi: "Critical requirement for cell cycle inhibitors in sustaining nonproliferative states." dans: The Journal of cell biology, Vol. 176, Issue 6, pp. 807-18, (2007) (PubMed).

Shih, Whalen, Goto, Hogg, van Eeden: "Flow cytometric method for enumeration and characterization of newly released polymorphonuclear leukocytes from the bone marrow using 5'-bromo-2'-deoxyuridine." dans: American journal of physiology. Cell physiology, Vol. 289, Issue 3, pp. C757-65, (2005) (PubMed).

Martín, Surur, García, Corrons, Badrán: "Comparative study of DNA synthesis and nucleolar organizer regions of sinusoid littoral cells in mouse regenerating liver." dans: Biocell : official journal of the Sociedades Latinoamericanas de Microscopía Electronica ... et. al, Vol. 29, Issue 1, pp. 33-8, (2005) (PubMed).

Muskhelishvili, Latendresse, Kodell, Henderson: "Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA." dans: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, Vol. 51, Issue 12, pp. 1681-8, (2003) (PubMed).

Magaud, Sargent, Clarke, Ffrench, Rimokh, Mason: "Double immunocytochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine." dans: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, Vol. 37, Issue 10, pp. 1517-27, (1989) (PubMed).

Détails sur BrdU

Antigène: BrdU (Bromodeoxyuridine (BrdU))

Autre désignation: BrdU

Classe de substances: Chemical

Sujet: Bromodexyuridine (BrdU) is a thymidine analog, which is selectively incorporated into the DNA of proliferating cells to provide a marker for the DNA being replicated. The number of proliferating cells can then be detected in cell lysates, tissue sections or suspensions using an antibody specific for the BrdU.,5-bromodeoxyuridine